Adaptilens was awarded $75,000 in the 2022 President’s Innovation Challenge for developing an intraocular lens that restores the eye’s ability to focus, offering a revolutionary approach to vision correction.
Adaptilens was awarded $75,000 in the 2022 President’s Innovation Challenge for developing an intraocular lens that restores the eye’s ability to focus, offering a revolutionary approach to vision correction.
